Yes — if you've been off semaglutide for more than a few weeks, most clinicians restart you at a low dose and re-titrate upward again, rather than resuming at whatever dose you stopped at. The reason is simple: the tolerance your body built up during your first round of titration fades once the medication clears your system, and restarting high risks the same nausea and GI side effects you worked through the first time.
If you're picking this back up after a pause — planned or not — here's what actually happens physiologically, why "start low and slow" applies again, and how to think about any weight regained in the meantime.
Why clinicians restart lower, not where you left off
Semaglutide has a half-life of about one week, which means it takes roughly four to five weeks for the drug to clear your system almost completely after your last dose. Once it's gone, so is the gradual adaptation your gut and appetite centers built up during your original titration schedule. Your body responds to a restarted dose closer to how it responded the first time you ever took it — which is exactly why a return to your previous maintenance dose can bring back first-injection-level nausea, vomiting, or GI discomfort.
Compounded medications are prepared on a per-patient basis by US-licensed compounding pharmacies, regulated under federal law (FDCA §503A) and by state boards of pharmacy. While these pharmacies are highly regulated, the compounded medications themselves are not FDA-approved, are not generic versions of brand-name drugs, and have not been evaluated by the FDA for safety, efficacy, or quality. Clinical trial outcomes for the FDA-approved products have not been established for compounded preparations. Individual results vary.
This is why a restart conversation with your clinician usually covers:
- How long you've been off the medication. A few missed weeks is a different conversation than several months — the longer the gap, the more tolerance has likely faded.
- Why you paused. Side effects, cost, supply, a life event, or a planned break all inform how your clinician approaches the restart.
- Any side effects you had the first time. If GI symptoms were rough during your original titration, that history shapes how conservatively your clinician re-titrates.
- What's changed in your health history since you stopped. New medications, procedures, or diagnoses matter just as much on a restart as they did at your original intake.
The exact re-titration schedule is a clinical decision your prescriber makes and adjusts based on your response — there's no single restart protocol that applies to everyone, and your clinician may move faster or slower than your original titration depending on how long you were off and how you tolerated it before.
What to expect physically when you restart
Broadly, restarting tends to echo your original first few weeks more than it echoes wherever you left off:
- GI symptoms can return, even if you'd built up a tolerance to your old maintenance dose. Mild nausea, constipation, or a few days of reduced appetite are common in the first week or two after a restarted dose, similar to what most people experience in their first three months on a GLP-1.
- Appetite suppression usually comes back fairly quickly, often sooner than the GI side effects fully settle.
- Injection-site or fatigue effects tend to be milder than GI symptoms on a restart, consistent with what most people report the first time around.
None of this is a sign that something has gone wrong — it's the expected pattern of reintroducing the medication after your body has had time to reset.
Does restarting mean starting completely over?
Not necessarily, and this is where it's worth separating two different questions: how your dose restarts, and how your body responds.
Your dose typically does restart at or near the beginning of a titration schedule, for the tolerance reasons above. But your body isn't a blank slate — some patients find they move through the early steps a bit more comfortably the second time, simply because they know what to expect and have strategies (hydration, smaller meals, anti-nausea approaches) already in place. That's an individual pattern, not something to count on, and it's not a reason to push your own titration faster than your clinician recommends.
What about weight regained during the break?
It's common to regain some weight during a pause, and that's worth naming plainly rather than around. In the STEP 4 trial, participants who stopped semaglutide after a lead-in period regained a substantial share of the weight they'd lost within about a year off the medication, while participants who continued treatment kept losing or held steady.
About the figures in this article
The STEP 4 finding above reflects FDA-approved Wegovy® (semaglutide) at the dose studied in that trial. It has not been clinically established for compounded preparations, and individual outcomes on restarting vary by how long you were off, what changed during the break, and your own response. Nothing here should be read as a prediction of your results.
If you're restarting after regain, a few things are useful to keep in mind:
- Regain after stopping is a known, expected pattern for this drug class — not a personal failure and not evidence the medication "stopped working" the first time. Appetite regulation tends to return toward baseline once the medication clears, which is a big part of why many patients and clinicians treat GLP-1 therapy as an ongoing, long-term treatment rather than a short course.
- Your clinician will treat this restart as a fresh evaluation, not just a resumption — your current weight, health markers, and goals are what inform your new plan, not just your history.
- The muscle-preservation basics still apply. If you lost lean mass along with fat during your first round — a common outcome without adequate protein and resistance training — those same habits matter just as much, if not more, on a restart. Our guide on protecting muscle during GLP-1 weight loss covers the specifics.
When a break might call for more than just a lower dose
Tell your clinician if any of the following happened during your time off — they can change how a restart is approached, or whether GLP-1 therapy is still the right fit:
- You developed a new health condition, started a new medication, or had a procedure or surgery since your last dose.
- You experienced significant side effects that led you to stop, especially anything beyond routine GI symptoms.
- You became pregnant, are currently pregnant, or are planning a pregnancy.
- It's been long enough that you're not sure your prior labs or health history are still current.
A restart is a good moment for your clinician to revisit your full picture, not just pick up the prescription where it left off.
If you've hit a plateau instead of a full stop
Not every "restart" question is really about a break — sometimes it's about a stall that feels like starting over. If that's your situation, our guide to GLP-1 weight-loss plateaus covers the difference between a genuine plateau and a normal pause in progress, and what a clinician typically looks at first.
Where Pallas fits
If you're restarting after a break, your intake goes to a US-licensed clinician who reviews your current health history — not just your prior prescription — and builds a titration plan around where you are now. Compounded semaglutide at Pallas is dispensed by US-licensed pharmacies with ongoing check-ins and care-team messaging, so dose adjustments during a restart are handled by the people managing your care, not left to guesswork. Availability and visit requirements vary slightly by state — you can check yours on our state-by-state GLP-1 guide.
Frequently asked questions
Usually your dose does restart at or near the beginning of a titration schedule, especially after more than a few weeks off — the tolerance you built up fades once the medication clears your system, and restarting at your old maintenance dose risks bringing back first-injection-level side effects. Your clinician decides the exact restart pace based on how long you were off and how you tolerated the medication before.
Semaglutide has a half-life of about one week, so it takes roughly four to five weeks to clear your system almost completely after your last dose. Once it's gone, the gradual adaptation your body built during your original titration goes with it, which is why a restart tends to feel more like your first few weeks than a resumption of where you left off.
It's common to regain some weight during a pause — in the STEP 4 trial, participants who stopped FDA-approved Wegovy® regained a substantial share of lost weight within about a year off the medication, while those who continued kept losing or held steady. That pattern reflects the FDA-approved product studied and hasn't been established for compounded preparations; individual outcomes vary. Regain during a break is an expected pattern for this drug class, not a sign anything went wrong.
Mild nausea, constipation, or a few days of reduced appetite are common in the first week or two after a restarted dose, similar to what most people experience when they first start. Appetite suppression tends to return fairly quickly, often before GI symptoms fully settle. None of this means something has gone wrong — it's the expected pattern of reintroducing the medication after a break.
How long you've been off, why you paused, any side effects from your original round, and anything that's changed in your health history since — new medications, procedures, diagnoses, or a pregnancy or plans for one. A restart is a fresh clinical evaluation, not just picking up an old prescription.
References
- Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414–1425.
- U.S. Food and Drug Administration. WEGOVY® (semaglutide) prescribing information. 2026.
- U.S. Food & Drug Administration. Human drug compounding — §503A. FDA.gov.
Bottom line: Semaglutide clears your system in a matter of weeks, and the tolerance you built up clears with it — which is why most clinicians restart a paused patient at a low dose and re-titrate, rather than resuming at the prior maintenance dose. Expect a return of early-titration-style GI symptoms, tell your clinician what changed during your break, and treat any regained weight as an expected part of the pattern rather than a setback to fix on your own.
Coming back after a break?
Share your history and how long you've been off in a 5-minute intake, and a US-licensed clinician will build a restart plan around where you are today.
Start your intake →